Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nova Vision Acquisition | NOVV | Dec 24, 2024 | 37.00 | 0.00 |
Novabay Pharmaceuticals | NBY | Dec 24, 2024 | 0.54 | +4.49 |
Novagold Resources | NG | Dec 24, 2024 | 3.30 | +0.92 |
Novanta | NOVT | Dec 24, 2024 | 155.56 | +1.13 |
Novartis ADR | NVS | Dec 24, 2024 | 98.35 | -0.10 |
Novavax | NVAX | Dec 24, 2024 | 8.51 | -1.50 |
Novo Nordisk ADR | NVO | Dec 24, 2024 | 87.37 | -1.51 |
NovoCure | NVCR | Dec 24, 2024 | 30.97 | +1.57 |
Novonix ADR | NVX | Dec 24, 2024 | 1.77 | +4.12 |
NRG Energy | NRG | Dec 24, 2024 | 93.03 | +0.86 |
NRx Pharmaceuticals | NRXP | Dec 24, 2024 | 1.57 | +10.56 |
NSTS Bancorp | NSTS | Dec 24, 2024 | 11.75 | +1.21 |
Nu Holdings | NU | Dec 24, 2024 | 10.37 | +1.27 |
Nu Skin Enterprises | NUS | Dec 24, 2024 | 6.66 | -1.04 |
Nuburu | BURU | Dec 24, 2024 | 0.43 | +1.69 |
NuCana ADR | NCNA | Dec 24, 2024 | 1.21 | -0.41 |
Nucor | NUE | Dec 24, 2024 | 117.43 | +0.70 |
Nukkleus | NUKK | Dec 24, 2024 | 36.51 | -12.57 |
Nurix Therapeutics | NRIX | Dec 24, 2024 | 19.57 | -2.05 |
NuScale Power | SMR | Dec 24, 2024 | 21.01 | +6.49 |
Nustar Energy C Pref | NS-C | Dec 24, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Dec 24, 2024 | 64.45 | -0.19 |
Nutex Health | NUTX | Dec 24, 2024 | 31.87 | +0.31 |
Nutriband | NTRB | Dec 24, 2024 | 3.89 | -2.24 |
Nutrien | NTR | Dec 24, 2024 | 44.50 | +0.07 |
Nuvalent A | NUVL | Dec 24, 2024 | 82.65 | -1.43 |
Nuvation Bio A | NUVB | Dec 24, 2024 | 2.82 | +5.62 |
Nuvectis Pharma | NVCT | Dec 24, 2024 | 4.65 | +1.53 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Dec 24, 2024 | 12.11 | +0.08 |
Nuveen Amtfree Municipal Value Fund | NUW | Dec 24, 2024 | 13.32 | -0.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.